R1	Has_context Arg1:T3 Arg2:T5	
R2	Has_multiplier Arg1:T3 Arg2:T4	
R3	Has_index Arg1:T6 Arg2:T7	
R4	Has_temporal Arg1:T9 Arg2:T10	
R5	Has_temporal Arg1:T3 Arg2:T6	
*	OR T18 T17
R6	Has_temporal Arg1:T12 Arg2:T13	
R7	Has_multiplier Arg1:T12 Arg2:T11	
R8	Has_context Arg1:T9 Arg2:T8	
*	OR T19 T20
R9	Has_value Arg1:T22 Arg2:T21	
R11	Has_multiplier Arg1:T28 Arg2:T27	
*	OR T26 T28
R10	Has_context Arg1:T26 Arg2:T25	
R12	Has_temporal Arg1:T26 Arg2:T29	
R13	Has_temporal Arg1:T26 Arg2:T30	
R14	AND Arg1:T23 Arg2:T26	
R15	Has_temporal Arg1:T35 Arg2:T36	
R16	Has_context Arg1:T35 Arg2:T34	
R17	Has_index Arg1:T13 Arg2:T14	
R18	Has_index Arg1:T30 Arg2:T31	
R19	AND Arg1:T23 Arg2:T24	
T1	Condition 15 25	bacteremia
T2	Parsing_Error 26 40	due solely to:
T3	Procedure 66 79	blood culture
T4	Multiplier 55 65	at least 1
T5	Observation 42 51	S. aureus
T6	Temporal 80 119	within 72 hours of beginning study drug
T7	Reference_point 99 119	beginning study drug
T8	Observation 135 139	MRSA
T9	Procedure 154 167	blood culture
T10	Temporal 145 153	baseline
T11	Multiplier 175 196	at least 1 additional
T12	Procedure 197 210	blood culture
T13	Temporal 211 276	after at least 72 hours of vancomycin and/or daptomycin treatment
T14	Reference_point 238 276	vancomycin and/or daptomycin treatment
T15	Drug 238 248	vancomycin
T16	Drug 256 266	daptomycin
T17	Procedure 256 276	daptomycin treatment
T18	Procedure 238 248;267 276	vancomycin treatment
T19	Person 293 297	Male
T20	Person 301 307	female
T21	Value 308 318	â‰¥ 18 years
T22	Person 322 325	age
T23	Person 334 340	female
T24	Condition 344 366	childbearing potential
T25	Observation 375 382	willing
T26	Procedure 386 412	practice sexual abstinence
T27	Multiplier 416 420	dual
T28	Procedure 421 445	methods of contraception
T29	Temporal 446 462	during treatment
T30	Temporal 467 521	for at least 30 days after the last dose of study drug
T31	Reference_point 494 521	the last dose of study drug
T34	Observation 527 538	Expectation
T35	Condition 542 550	survival
T36	Temporal 551 572	for at least 2 months
